MBRX
MBRX
NASDAQ · Biotechnology

Moleculin Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$2.47
-0.02 (-0.80%)
As of May 16, 2:29 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +929.6% upside
Low Target $14.54
Average Target $25.43
High Target $32.33
Current Price $2.47
Current
$2.47
Target
$25.43
$14.54 $25.43 avg $32.33
Scenario Analysis
Bear Case
$14.54
488.7%
Low target
Base Case
$25.43
+929.6%
Avg target
Bull Case
$32.33
+1,208.9%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$26.12
-90.5% from high
52-Week Low
$1.79
+38.0% from low
Target vs 52W High
$25.43
-2.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%